Patients Receiving Rasburicase for Treatment and Prophylaxis of Tumor Lysis Syndrome Are Under-Tested for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: A Single Center Retrospective Analysis
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:11054-11055 - Subject
- Language
- ISSN
- 0006-4971